Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and Phlegmon

carbapenems has been researched along with Phlegmon in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Imafuku, K; Itamoto, S; Kawamura, T; Kimura, A; Kosumi, H; Mai, Y; Muramatsu, K; Nakakubo, S; Shiiya, C; Ujiie, H; Yamada, M; Yanagi, T; Youh, J1
Amaral, AJ; Frosini, SM; Loeffler, A; Menezes, J; Pomba, C1
Lucht, F; Magand, F1

Other Studies

3 other study(ies) available for carbapenems and Phlegmon

ArticleYear
Macrolide/fluoroquinolone-resistant Campylobacter jejuni-induced cellulitis in a patient with X-linked agammaglobulinaemia successfully treated with carbapenem.
    Dermatologic therapy, 2021, Volume: 34, Issue:6

    Topics: Agammaglobulinemia; Anti-Bacterial Agents; Campylobacter jejuni; Carbapenems; Cellulitis; Drug Resistance, Bacterial; Fluoroquinolones; Genetic Diseases, X-Linked; Humans; Macrolides

2021
Dissemination of bla
    Journal of infection and public health, 2023, Volume: 16 Suppl 1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cellulitis; Dogs; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids

2023
[Campylobacter jejuni cellulitis].
    Annales de dermatologie et de venereologie, 2009, Volume: 136, Issue:12

    Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Cellulitis; Drug Administration Schedule; Humans; Inflammation; Male; Middle Aged

2009